CLINICAL_TRIALS
trial_result
· 2012-03-15
Clinical Trial Update: Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) In The Treatment Of Major Depressive Disorder [Phase 3]
Summary
Phase 3 study evaluating desvenlafaxine succinate sustained release (DVS SR) for major depressive disorder; results were posted after completion.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Depressive Disorder, Major | Phase 3 | Status: COMPLETED | Results posted: 2012-03-15